Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3

NCT04268173

Conditions
Behavior, Blood-Borne Infections, Chemically-Induced Disorders, +17 more
Locations
  • Vivent Health Appleton, Wisconsin, United States
  • Vivent Health Eau Claire, Wisconsin, United States
  • Vivent Health Green Bay, Wisconsin, United States
  • Vivent Health La Crosse, Wisconsin, United States
View Trial Details
Completed

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

NCT03740230

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • SoonChunHyang University CheonAn Hospital /ID# 209996 Cheonan-si, Chungcheongnam-do, South Korea
  • Hallym University Sacred Heart Hospital /ID# 210809 Anyang, Gyeonggido, South Korea
  • The Catholic University of Korea, Bucheon St.Mary's Hospital /ID# 216869 Bucheon-si, Gyeonggido, South Korea
  • Dongguk University Ilsan Hospital /ID# 210609 Goyang, Gyeonggido, South Korea
View all 61 locations
View Trial Details
Completed

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

NCT04042740

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
Locations
  • Ucsd, Avrc Crs (701) San Diego, California, United States
  • University of California, San Francisco HIV/AIDS CRS (801) San Francisco, California, United States
  • University of Colorado Hospital CRS (6101) Aurora, Colorado, United States
  • Whitman-Walker Institute, Inc. CRS (31791) Washington D.C., District of Columbia, United States
View Trial Details
Completed

Maraviroc Efficacy for Hepatitis C

NCT02881762

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Institute of Human Virology at the University of Maryland School of Medicine Baltimore, Maryland, United States
View Trial Details

Related conditions